These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1097 related articles for article (PubMed ID: 18367132)

  • 1. Model for End-stage Liver Disease score fails to predict perioperative outcome after hepatic resection for hepatocellular carcinoma in patients without cirrhosis.
    Teh SH; Sheppard BC; Schwartz J; Orloff SL
    Am J Surg; 2008 May; 195(5):697-701. PubMed ID: 18367132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recovery from liver failure after hepatectomy for hepatocellular carcinoma in cirrhosis: meaning of the model for end-stage liver disease.
    Cucchetti A; Ercolani G; Cescon M; Ravaioli M; Zanello M; Del Gaudio M; Lauro A; Vivarelli M; Grazi GL; Pinna AD
    J Am Coll Surg; 2006 Nov; 203(5):670-6. PubMed ID: 17084328
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved outcome of adult recipients with a high model for end-stage liver disease score and a small-for-size graft.
    Yi NJ; Suh KS; Lee HW; Shin WY; Kim J; Kim W; Kim YJ; Yoon JH; Lee HS; Lee KU
    Liver Transpl; 2009 May; 15(5):496-503. PubMed ID: 19399732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is portal hypertension a contraindication to hepatic resection?
    Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; Ramacciato G; Grazi GL; Pinna AD
    Ann Surg; 2009 Dec; 250(6):922-8. PubMed ID: 19855258
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The correlation of Child-Pugh score, PGA index and MELD score in the patient with liver cirrhosis and hepatocellular carcinoma according to the cause of alcohol and hepatitis B virus].
    Mun BS; Ahn HS; Ahn DS; Lee SO
    Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):107-15. PubMed ID: 12824750
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of model for end-stage liver disease (MELD) score on prognosis after hepatectomy for hepatocellular carcinoma on cirrhosis.
    Cucchetti A; Ercolani G; Vivarelli M; Cescon M; Ravaioli M; La Barba G; Zanello M; Grazi GL; Pinna AD
    Liver Transpl; 2006 Jun; 12(6):966-71. PubMed ID: 16598792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Minor versus major hepatic resection for small hepatocellular carcinoma (HCC) in cirrhotic patients: a 20-year experience.
    Dahiya D; Wu TJ; Lee CF; Chan KM; Lee WC; Chen MF
    Surgery; 2010 May; 147(5):676-85. PubMed ID: 20004441
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perioperative and long-term outcome of major hepatic resection for small solitary hepatocellular carcinoma in patients with cirrhosis.
    Lang BH; Poon RT; Fan ST; Wong J
    Arch Surg; 2003 Nov; 138(11):1207-13. PubMed ID: 14609868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indication of the extent of hepatectomy for hepatocellular carcinoma on cirrhosis by a simple algorithm based on preoperative variables.
    Cescon M; Cucchetti A; Grazi GL; Ferrero A; Viganò L; Ercolani G; Zanello M; Ravaioli M; Capussotti L; Pinna AD
    Arch Surg; 2009 Jan; 144(1):57-63; discussion 63. PubMed ID: 19153326
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic resection for hepatocellular carcinoma in diameter of > or = 10 cm.
    Hanazaki K; Kajikawa S; Shimozawa N; Shimada K; Hiraguri M; Koide N; Adachi W; Amano J
    Hepatogastroenterology; 2002; 49(44):518-23. PubMed ID: 11995486
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatic resection for hepatocellular carcinoma existing with liver cirrhosis.
    Ezaki T; Yamamoto K; Yamaguchi H; Sasaki Y; Ishida T; Mori M; Aimitsu S
    Hepatogastroenterology; 2002; 49(47):1363-8. PubMed ID: 12239943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MELD-Na is an independent short- and long-term prognostic predictor for hepatocellular carcinoma: a prospective survey.
    Huo TI; Lin HC; Hsia CY; Huang YH; Wu JC; Chiang JH; Chiou YY; Lui WY; Lee PC; Lee SD
    Dig Liver Dis; 2008 Nov; 40(11):882-9. PubMed ID: 18339595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of model for end-stage liver disease score to serum sodium ratio index as a prognostic predictor in patients with cirrhosis.
    Lv XH; Liu HB; Wang Y; Wang BY; Song M; Sun MJ
    J Gastroenterol Hepatol; 2009 Sep; 24(9):1547-53. PubMed ID: 19686416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The model for end-stage liver disease score is the best prognostic factor in human immunodeficiency virus 1-infected patients with end-stage liver disease: a prospective cohort study.
    Murillas J; Rimola A; Laguno M; de Lazzari E; Rascón J; Agüero F; Blanco JL; Moitinho E; Moreno A; Miró JM;
    Liver Transpl; 2009 Sep; 15(9):1133-41. PubMed ID: 19718643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term results of hepatic resection for hepatocellular carcinoma originating from the noncirrhotic liver.
    Chang CH; Chau GY; Lui WY; Tsay SH; King KL; Wu CW
    Arch Surg; 2004 Mar; 139(3):320-5; discussion 326. PubMed ID: 15006892
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of united hepatectomy and splenectomy in the surgical treatment of hepatocellular carcinoma complicated with hepatic cirrhosis and hypersplenism].
    Chen XP; Wu ZD; Qiu FZ
    Zhonghua Wai Ke Za Zhi; 2005 Apr; 43(7):442-6. PubMed ID: 15854370
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is resection for large hepatocellular carcinoma in cirrhotic patients beneficial? Study of 38 cases.
    Abdel-Wahab M; Sultan A; el-Ghawalby A; Fathy O; el-Ebidy G; Abo-Zeid M; Aboel-Enin A; Abdallah T; Fouad A; el-Fiky A; Gadel-Hak N; Ezzat F
    Hepatogastroenterology; 2001; 48(39):757-61. PubMed ID: 11462920
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Child-Turcotte-Pugh versus MELD score as a predictor of outcome after elective and emergent surgery in cirrhotic patients.
    Farnsworth N; Fagan SP; Berger DH; Awad SS
    Am J Surg; 2004 Nov; 188(5):580-3. PubMed ID: 15546574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatic resection of hepatocellular carcinoma in patients with cirrhosis: Model of End-Stage Liver Disease (MELD) score predicts perioperative mortality.
    Teh SH; Christein J; Donohue J; Que F; Kendrick M; Farnell M; Cha S; Kamath P; Kim R; Nagorney DM
    J Gastrointest Surg; 2005 Dec; 9(9):1207-15; discussion 1215. PubMed ID: 16332475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determination of the optimal model for end-stage liver disease score in patients with small hepatocellular carcinoma undergoing loco-regional therapy.
    Huo TI; Wu JC; Lin HC; Lee FY; Hou MC; Huang YH; Lee PC; Chang FY; Lee SD
    Liver Transpl; 2004 Dec; 10(12):1507-13. PubMed ID: 15558587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 55.